MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
201.02%
Quick Ratio
201.02%
Debt to Asset Ratio
49.33%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash
    • Prepaid expenses and other curre...
    • Right-of-use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
5,028
9,177
1,884
3,047
Other receivables
-
-
95
153
Due from related party
83
95
750
-
Prepaid expenses and other current assets
783
724
404
179
Total current assets
5,894
9,996
3,133
3,379
Property and equipment, gross
-
-
291
-
Less accumulated depreciation and amortization
-
-
197
-
Property and equipment, net
82
88
94
92
Right-of-use assets - operating leases, net
314
349
453
541
Goodwill
-
-
2,044
2,044
Other assets
25
110
110
116
Total assets
6,315
10,543
5,834
6,172
Accounts payable
1,375
1,300
1,125
958
Accrued expenses
1,016
1,481
898
859
Income taxes payable
-
4
3
17
Operating lease liabilities, current
167
163
213
206
Due to related party
250
250
750
-
Contingent consideration liability
-
41
41
41
Other current liabilities
124
218
83
63
Total current liabilities
2,932
3,457
3,113
2,144
Operating lease liabilities, non-current
182
226
277
346
Other liabilities
1
1
43
112
Total liabilities
3,115
3,684
3,433
2,602
Preferred stock, 0.005 par value, 1,000 shares authorized, 156 designated and outstanding of series a convertible preferred stock at june 30, 2026 and december 31, 2025, 156 liquidation preference
1
1
1
1
Common stock, 0.005 par value, 150,000 shares authorized at june 30, 2026 and december 31, 2025, 1,170 and 314 issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
6
39
39
Additional paid-in capital
258,352
257,994
247,997
247,656
Accumulated deficit
-255,159
-251,142
-245,636
-244,126
Total stockholders equity
3,200
6,859
2,401
3,570
Total liabilities and stockholders equity
6,315
10,543
5,834
6,172
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$5,028K Prepaid expenses andother current assets$783K Due from relatedparty$83K Total current assets$5,894K Right-of-use assets -operating leases, net$314K Property and equipment,net$82K Other assets$25K Total assets$6,315K (-16.73%↓ Y/Y)Total liabilities andstockholders equity$6,315K (-16.73%↓ Y/Y)Total stockholdersequity$3,200K (-27.99%↓ Y/Y)Total liabilities$3,115K (-0.80%↓ Y/Y)Accumulated deficit-$255,159K (-5.05%↓ Y/Y)Additional paid-in capital$258,352K (4.47%↑ Y/Y)Total currentliabilities$2,932K (10.60%↑ Y/Y)Operating leaseliabilities, non-current$182K (-51.60%↓ Y/Y)Other liabilities$1K (-99.12%↓ Y/Y)Common stock, 0.005 parvalue, 150,000 shares...$6K (-83.78%↓ Y/Y)Preferred stock, 0.005 parvalue, 1,000 shares...$1K (0.00%↑ Y/Y)Accounts payable$1,375K (4.25%↑ Y/Y)Accrued expenses$1,016K (8.32%↑ Y/Y)Due to related party$250K Operating leaseliabilities, current$167K (-23.04%↓ Y/Y)Other currentliabilities$124K (-0.80%↓ Y/Y)

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Inc. (ERNA)